课题基金 / 基金详情

Establishment of transgenic mice that recognize bacteria specific antigen and develop spontaneous colitis under specific pathogen free condition.

Establishment of transgenic mice that recognize bacteria specific antigen and develop spontaneous colitis under specific pathogen free condition.
建立识别细菌特异性抗原并在无特定病原体条件下产生自发性结肠炎的转基因小鼠。
批准号:
15590627
负责人:
KANAI Takanori
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

KANAI Takanori的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In this study, we clarified that intestinal bacteria flora is essential for the development of chronic colitis using murine model of chronic colitis. We in general used adoptive transfer model that normal CD4+CD45RBhigh T cells from spleens are transferred into SCID mice. This model has the strong advadvantages that we can exactly evaluate the pathogenic T cells in clonal level.We are now under investigation to establish bacteria-specidfic antigen recognizing TCR transgenic mouse after the isolation of TCRab genes. Using this model, we believe that we can brake through to understand the exact mechanism of action in terms of antigen-specific analysis. Furthermore, we will find out a new strategy using probiotics for the treatment of inflammatory bowel diseases.
期刊论文(56)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1053/j.gastro.2005.03.085
发表时间: 2005-06-01
期刊: GASTROENTEROLOGY
影响因子: 29.4
作者: [Matsumoto, T, Okamoto, R, Watanabe, M]
通讯作者: Watanabe, M
Human intestinal epithelia-derived IL-18 is a potent prolifrerative factor for intraepithelial lymphocytes synergistically with IL-2, IL-7 and IL-15.
人肠上皮来源的 IL-18 是上皮内淋巴细胞的有效增殖因子,与 IL-2、IL-7 和 IL-15 具有协同作用。
DOI: --
发表时间: 2004
期刊: Clin Exp Immunol 136
影响因子: --
作者: [Okazawa A, Kanai T, Nakamaru T, Sato T, Inoue N, Ogata H, Iwao Y, Ikeda M, Kawamura T, Makita S, Uraushihara K, Okamoto R, Yamazaki M, Kurimoto M, Ishii H, Watanabe M, Hibi T.]
通讯作者: Hibi T.
Interferon regulatory factor 1 (IRF-1) and IRF-2 distinctively up-regulate gene expression and production of IL-7 in human intestinal epithelial cells.
干扰素调节因子 1 (IRF-1) 和 IRF-2 明显上调人肠上皮细胞中基因表达和 IL-7 的产生。
DOI: --
发表时间: 2004
期刊: Mol Cell Biol 24
影响因子: --
作者: [Oshima S, Kanai T, et al.]
通讯作者: et al.
T-bet up-regulation and subsequent interleukin 12 stimulation are essential for the induction of Th1 mediated immunopathology in Crohn's disease.
T-bet 上调和随后的白细胞介素 12 刺激对于克罗恩病中 Th1 介导的免疫病理学的诱导至关重要。
DOI: --
发表时间: 2004
期刊: Gut 53
影响因子: --
作者: [Matsuoka K, Inoue N, Sato T, Okamoto S, Hisamatsu T, Kishi Y, Sakuraba A, Hitotsumatsu O, Fukushima T, Kanai T, Watanabe M, Ishii H, Hibi T]
通讯作者: Hibi T
37
    The elucidation of the World of AhR in the intestinal environment ,followed by the diverse clinical applications.
    • 批准号:
      18KK0246
    • 项目类别:
      Fund for the Promotion of Joint International Research (Fostering Joint International Research (B))
    • 资助金额:
      $10.98万
    • 财政年份:
      2019
    • 负责人:
      KANAI Takanori
    • 依托单位:
    Identification of Symbiosis pattern decision factors and its reeducation program
    • 批准号:
      24390190
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.65万
    • 财政年份:
      2012
    • 负责人:
      KANAI Takanori
    • 依托单位:
    Challenge to the cell therapy by reprogramming colitogenic memory T cells
    • 批准号:
      24659375
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2012
    • 负责人:
      KANAI Takanori
    • 依托单位:
    Permanent cure strategy of inflammatory bowel diseases by inducing immunological reset
    • 批准号:
      21390233
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.65万
    • 财政年份:
      2009
    • 负责人:
      KANAI Takanori
    • 依托单位:
    海外基金